Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 7,776–7,800 of 7,816 matching trials · page 312 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects With Alzheimer's Disease NCT00069849 ABT-089 Runs in: United States · 8 sites |
PHASE2 other |
TERMINATED | 64 | Abbott INDUSTRY |
2006-09-04 |
|
Study of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in Alzheimer's Disease, Vascular Dementia, and Mixed Vascular and Alzheimer's Dementia NCT00229333 Escitalopram Runs in: Israel · 1 site |
PHASE4 other |
UNKNOWN | 40 | Sheba Medical Center OTHER_GOV |
2006-08-29 |
|
Preventing Cognitive Decline With Alternative Therapies NCT00010920 Ginkgo Biloba Extract Runs in: United States · 1 site |
PHASE3 other |
COMPLETED | — | National Center for Complementary and Integrative Health (NCCIH) NIH |
2006-08-18 |
|
Creatine Therapy for Huntington's Disease NCT00026988 Creatine Runs in: United States · 4 sites |
PHASE1|PHASE2 other |
COMPLETED | 64 | National Center for Complementary and Integrative Health (NCCIH) NIH |
2006-08-18 |
|
Study of Depakote for Behavioral and Psychological Symptoms in Dementia NCT00197834 Depakote Runs in: United States · 1 site |
PHASE1 other |
UNKNOWN | 20 | Hearthstone Alzheimer Care INDUSTRY |
2006-08-15 |
|
Guanfacine to Treat Borderline Personality Disorder NCT00358969 guanfacine (Tenex) Runs in: United States · 1 site |
NA other |
UNKNOWN | — | Icahn School of Medicine at Mount Sinai OTHER |
2006-08-01 |
|
Care Management for Patients With Alzheimer Disease and Their Family Caregivers NCT00246896 care management Runs in: United States · 1 site |
NA other |
COMPLETED | 220 | Agency for Healthcare Research and Quality (AHRQ) OTHER_GOV |
2006-07-27 |
|
High Intensity Light Therapy in Alzheimer's Disease NCT00065689 high-intensity light therapy Runs in: United States · 1 site |
PHASE3 other |
COMPLETED | 107 | National Center for Complementary and Integrative Health (NCCIH) NIH |
2006-07-26 |
|
Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease NCT00051909 LY451395 Runs in: United States · 9 sites |
PHASE2 other |
COMPLETED | 200 | Eli Lilly and Company INDUSTRY |
2006-07-19 |
|
Multidisciplinary Inpatient Palliative Care Intervention NCT00325611 Multidisciplinary palliative care team met with patient Runs in: United States · 1 site |
NA other |
COMPLETED | 550 | Kaiser Permanente OTHER |
2006-05-15 |
|
Computer-Based Therapy for Mild Cognitive Impairment NCT00319943 Computer-based training for Mild Cognitive Impairment (MCI) Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 48 | Posit Science Corporation INDUSTRY |
2006-04-27 |
|
Randomized Study of Two Interventions for Liquid Aspiration: Short-Term and Long-Term Effects NCT00000362 Chin-down position; Thickened liquid administration Runs in: United States · 1 site |
PHASE3 other |
TERMINATED | 600 | National Institute on Deafness and Other Communication Disorders (NIDCD) NIH |
2006-04-24 |
|
TNF-Alpha Inhibition for Treatment of Alzheimer's Disease NCT00203320 etanercept given by perispinal administration Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 30 | Tobinick, Edward Lewis, M.D. OTHER |
2006-04-24 |
|
TNF-Alpha Inhibition for Treatment of Alzheimer's Disease NCT00203359 etanercept given by perispinal administration Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 15 | Tobinick, Edward Lewis, M.D. OTHER |
2006-04-24 |
|
Risperidone Alone Vs. Risperidone Plus Valproate in the Treatment of Patients With Schizophrenia and Hostility NCT00308360 Risperidone, divalproex Runs in: United States · 1 site |
PHASE4 other |
COMPLETED | 46 | Nathan Kline Institute for Psychiatric Research OTHER |
2006-03-29 |
|
Risperidone Augmentation for Treatment-Resistant Aggression in ADHD NCT00297739 Risperidone Runs in: United States · 1 site |
PHASE4 other |
COMPLETED | 25 | Armenteros, Jorge L., M.D., P.A. OTHER |
2006-03-16 |
|
Memantine and Down's Syndrome NCT00240760 Memantine Hydrochloride Runs in: United Kingdom · 2 sites |
NA symptomatic-cholinergic |
UNKNOWN | 180 | King's College London OTHER |
2006-02-20 |
|
Study of the Effect of SR57667B in Patients With Alzheimer's Disease NCT00285025 SR57667B |
PHASE2 other |
COMPLETED | 500 | Sanofi INDUSTRY |
2006-02-01 |
|
MRS and DTI of White Matter in Alzheimer's Disease NCT00172900 Runs in: Taiwan · 1 site |
NA other |
UNKNOWN | 40 | National Taiwan University Hospital OTHER |
2005-12-21 |
|
Safety and Efficacy of Galantamine in Patients With Dementia With Lewy Bodies NCT00230997 Galantamine Runs in: United States · 5 sites |
PHASE3 symptomatic-cholinergic |
COMPLETED | 50 | Neurological Research Center INDUSTRY |
2005-12-16 |
|
CALM-AD NCT00142324 Donepezil Runs in: United Kingdom · 8 sites |
PHASE4 symptomatic-cholinergic |
UNKNOWN | 190 | Institute of Psychiatry, London OTHER |
2005-12-14 |
|
Metabolic Syndrome, Inflammation, and Risk of Cognitive Decline NCT00099567 Runs in: United States · 2 sites |
NA other |
COMPLETED | 2,632 | National Institute on Aging (NIA) NIH |
2005-11-01 |
|
Influence of Age on Hemispheric Lateralization of Language : a Longitudinal Study NCT00241293 Runs in: France · 1 site |
NA other |
COMPLETED | — | University Hospital, Tours OTHER |
2005-10-18 |
|
Efficacy and Safety of Tetrabenazine in Chorea NCT00219804 tetrabenazine or placebo |
PHASE3 other |
COMPLETED | — | Prestwick Pharmaceuticals INDUSTRY |
2005-09-22 |
|
Double Blind Study of Trp01 in Patients With Alzheimer's Disease NCT00202124 Tryptophan Runs in: Canada · 1 site |
PHASE4 other |
COMPLETED | 12 | Queen's University OTHER |
2005-09-20 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial